Yongsong Wu, Shilin Xu, Shanshan Cheng, Jiani Yang, & Yu Wang. (2023). Clinical application of PARP inhibitors in ovarian cancer: From molecular mechanisms to the current status. BMC.
Chicago Style (17th ed.) CitationYongsong Wu, Shilin Xu, Shanshan Cheng, Jiani Yang, and Yu Wang. Clinical Application of PARP Inhibitors in Ovarian Cancer: From Molecular Mechanisms to the Current Status. BMC, 2023.
MLA (9th ed.) CitationYongsong Wu, et al. Clinical Application of PARP Inhibitors in Ovarian Cancer: From Molecular Mechanisms to the Current Status. BMC, 2023.
Warning: These citations may not always be 100% accurate.